Gonadotropin-releasing hormone agonist use in assisted reproduction cycles: the influence of long and short regimens on pregnancy rates - cycle performance and in vitro steroidogenesis of granulosa-lutein cells

By Cramer D.W.   Powers D.R.   Oskowitz S.P.   Liberman R.F.   Hornstein M.D.   McShane P.M.   Barbieri R.L.  

Fertility and Sterility, Vol. 72, Iss. 1, 1999-07 ,pp. : 83-89

Elsevier

Access to resources Recommend Favorite

Effects of a Gonadotropin-Releasing Hormone agonist and Follicle Stimulating Hormone on the incidence of apoptosis in human luteinized granulosa cells

By Sifer C.   Blanc-Layrac G.   Bringuier A.-F.   Porcher R.   Madelenat P.   Feldmann G.   Benifla J.-L.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 110, Iss. 1, 2003-09 ,pp. : 43-48

Elsevier

Access to resources Recommend Favorite

Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon)

By de Jong D.   Macklon N.S.   Eijkemans M.J.C.   Mannaerts B.M.J.L.   Coelingh Bennink H.J.T.   Fauser B.C.J.M.   for the Ganirelix Dose-Finding Study Group  

Fertility and Sterility, Vol. 75, Iss. 4, 2001-04 ,pp. : 688-693

Elsevier

Access to resources Recommend Favorite

Sperm to zona pellucida binding depends on the use of a gonadotropin-releasing hormone agonist or a gonadotropin-releasing hormone antagonist

By Schroder A.K.   Schopper B.   Al-Hasani S.   Loning M.   Diedrich K.   Ludwig M.  

Fertility and Sterility, Vol. 79, Iss. 3, 2003-03 ,pp. : 648-650

Elsevier

Access to resources Recommend Favorite

Impact of the gonadotropin-releasing hormone antagonist in oocyte donation cycles

By Ricciarelli E.   Sanchez M.   Martinez M.   Andres L.   Cuadros J.   Hernandez E.R.  

Fertility and Sterility, Vol. 79, Iss. 6, 2003-06 ,pp. : 1461-1463

Elsevier

Access to resources Recommend Favorite